Stay updated on FG-4592 Efficacy/Safety in MDS Anemia Clinical Trial
Sign up to get notified when there's something new on the FG-4592 Efficacy/Safety in MDS Anemia Clinical Trial page.

Latest updates to the FG-4592 Efficacy/Safety in MDS Anemia Clinical Trial page
- Check2 days agoChange DetectedNo meaningful differences are observed between the screenshots. The study details page remains substantially the same.SummaryDifference0.3%

- Check10 days agoNo Change Detected
- Check31 days agoChange DetectedAdded a government-status notice and a v3.2.0 revision; removed the v3.1.0 revision. The page now informs users about potential delays and where to check current operating status, and indicates the new version.SummaryDifference4%

- Check38 days agoChange DetectedCore content shifted with a new version (v3.1.0) and removal of several drug-safety subsections (e.g., Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the prior version.SummaryDifference0.5%

- Check53 days agoChange DetectedUpdated page version from v3.0.1 to v3.0.2. The Back to Top link was removed, a minor UI change.SummaryDifference0.3%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%

- Check67 days agoChange DetectedThe web page has been updated to include specific facility names and locations in Beijing, Shanghai, and Tianjin, along with new content related to drug safety and specific medical conditions. Previous references to broader location terms and certain diseases have been removed.SummaryDifference3%

Stay in the know with updates to FG-4592 Efficacy/Safety in MDS Anemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-4592 Efficacy/Safety in MDS Anemia Clinical Trial page.